BioCentury | Nov 10, 2020
Finance
Nov. 9 Quick Takes: Biogen sheds $14B in value; plus Ambrx’s 200M round, Decibel’s series D and more
...also seeking to create an innovative pipeline of its own. The round also included contributions from Panacea Venture...